|
|
|
|
14th International Workshop on
HIV and Aging
26-27 October 2023
|
|
|
- High Rate of Metabolic Comorbidities in Young Adults With HIV Acquired Around Birth - (11/16/23)
 
-
HIV-1 Soluble GP120 Is Associated With Immune Dysfunction
and Inflammation in Individuals With Undetectable Viremia - in 33% of PWH - (11/06/23)
 
- Epigenetic Age Advancement [5.4 years] is Associated with Lower CD4 T-cell Count, Increased Mortality Risk, and Frailty in Older Adults with HIV - (11/03/23)
 
- Immunogenicity of High Dose Flu Vaccine in Aging PWH, Premature Senesence - (11/03/23)
 
- The CD38-NAD+ Axis: A Key Mediator of Inflammaging in
HIV Infection: immune exhaustion, age-associated comorbiditied - (11/03/23)
 
-
Aging with HIV: social Isolation & Loneliness, Animal Therapy Intervention - (11/02/23)
 
- CNS complications in people aging with HIV - (11/02/23)
 
- Session 5: Lightning Poster Presentations - (11/02/23)
 
- Plasma proteomic signatures capture unique cardiovascular risk phenotypes among persons living with and without HIV in the United States:
Plasma Proteome [biomarkers] Offers Insights Beyond Traditional CVD Risk Factors - Reported by Mark Mascolini for NATAP and Academic Medical Education(11/02/23)
 
- Clustering Frailty Components May Enable Sharper Comorbidity Insights - (11/02/23)
 
- Multifactorial Risk Factors for Cognitive Impairment - (11/02/23)
 
- Cognitive Frailty in People Living With HIV and Its Association With Geriatric Syndromes - (11/02/23)
 
- Session 2: Sarcopenia and Frailty Prevention & Treatment - (11/02/23)
 
- Underlying Mechanisms of Asymptomatic Neurocognitive Impairment - (11/01/23)
 
- Emotional, Not Social, Loneliness Is Related to Objective Cognitive Function in Older People With HIV - (11/01/23)
 
-
2 Oral Talks - PLWH: Sarcopenia, Mitochondrial Function - (11/01/23)
 
- HIV Smoking Quitters Older and Have More Comorbidities Than Current Smokers - Reported by Mark Mascolini for NATAP and Academic Medical Education (10/31/23)
 
- Switching to a Fixed-Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed, Treatment-Experienced People with HIV (PWH) ≥ 65 Years Old - (10/31/23)
 
- Relationships between plasma neurofilament light
chain protein, cognition, and brain aging in people with HIV - (10/31/23)
 
- An integrated HIV-Geriatric Clinic Model: Lessons from Newlands Clinic, Harare Zimbabwe - (10/31/23)
 
- PWH Have Higher depression Rates Than People without HIV: Some Depressive Symptoms Wane With Age in HIV Group-Some Do Not - (10/31/23)
 
- The longitudinal impact of depressive symptoms and frailty on social support: depression contributes to declining social support - Reported by Mark Mascolini for NATAP and Academic Medical Education (10/31/23)
 
- Emotional (but not Social) Loneliness Tied to Cognition in Older People With HIV - Reported by Mark Mascolini for NATAP and Academic Medical Education (10/30/23)
 
- Implementation of a multidisciplinary approach to
care for people living with HIV aged over 80 years - Reported by Mark Mascolini for NATAP and Academic Medical Education (10/30/23)
 
- Global Survey: "62% in low and middle income & 29% in high income countries are mostly unaware for developing health complications as they get older" - (10/30/23)
 
- Cognitive Function Fell in 25% of Canadian HIV Group Over 10 Years - Reported by Mark Mascolini for NATAP and Academic Medical Education (10/30/23)
 
- Long-term effect of dolutegravir use on more depressive symptoms among older people with HIV - Reported by Mark Mascolini for NATAP and Academic Medical Education (10/30/23)
 
- Cognitive Frailty Threatens People With HIV at a Younger Age - Reported by Mark Mascolini for NATAP and Academic Medical Education (10/30/23)
 
- Older Age, More Comorbidities
Mean Lower Chance of ART With Medicare - Reported by Mark Mascolini for NATAP and Academic Medical Education (10/30/23)
 
- Prefrail or frail older people with HIV live in
more disadvantaged areas than older HIV-positive nonfrail people - Reported by Mark Mascolini for Academic Medical Education and NATAP (10/30/23)
 
-
High Rate of Metabolic Comorbidities in Young Adults With HIV Acquired Around Birth - Reported by Mark Mascolini for Academic Medical Education and NATAP (10/30/23)
 
- Aging, Comorbidities, Frailty, Polypharmacy for PLWH > 80 Years at Chelsea Westminster London HIV Clinic - Reported by Mark Mascolini for NATAP and Academic Medical Education (10/30/23)
 
- HIV in the Brain & Cognitive Impairment: Despite Viral Suppression [blood brain permeability] women with HIV have double stroke risk & non-Hispanic African-Americans have 3.5 higher stroke incidence - the 6Ms for managing PLWH in the clinic; neurotoxicity of ARTs - (10/30/23)
 
|
|
|
|
|
|
|
|
|